Allergy Immunotherapy Market Report 2025 (Global Edition)

Global Allergy Immunotherapy Market Report 2025 Market Size Split by Indication (Allergic Rhinitis, Allergic Asthma, Food Allergy, Atopic Dermatitis, Others), by Distribution Channel (Hospital Pharmac...

Allergy Immunotherapy Market Report Description

We have various report editions of Allergy Immunotherapy Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Allergy Immunotherapy Market Insights Video

Company Profile

ALK

ALK is based in Denmark and is a pharmaceutical company focused on allergy and allergic asthma. The company offered a wide range of allergy immunotherapy treatments and other products and services which meet the unique needs of allergy sufferers, their families, and healthcare professionals. The company provides various solutions such as diagnosing allergy, allergy vaccines, and emergency medicine. The company has adopted a unique production approach which includes raw materials in the form of natural allergens like grass pollen and house dust mites. The Company produces API and formulates the vaccine which is distributed all across the world. The company offers the allergy immunotherapy treatment causes due to allergens such as house dust mite, grass, trees from the birch tree family, ragweed and Japanese cedar. 

The brands available for USA are 
     ODACTRA- It is an allergen extract indicated as immunotherapy for house dust mite (HDM)
     GRASTEK- It is an allergen extract indicated as immunotherapy for the treatment of grass pollen
     RAGWITEK- It is an allergen extract indicated as immunotherapy for the treatment of short ragweed.
Alutard SQ Bee & Wasp, Jext, Grazax, Soluprick SQ are brand available in United Kingdom

RECENT NEWS

• September 2019, Germany becomes the first to launch market for ALK’s tree SLIT-tablet

ALK has confirmed the first launch of its sublingual allergy immunotherapy (SLIT) tablet, ITULAZAX®, in Germany after the company received national approval from authorities. This product branded ITULAZAX® is indicated for the treatment of tree pollen allergy.

Top Companies Market Share in Allergy Immunotherapy Industry: (In no particular order of Rank)

• ALK
• Stallergenes Greer
• HAL Allergy Holding B.V.
• Allergy Therapeutics
• DBV Technologies
• Aimmune Therapeutics Inc
• Allergopharma (Derma pharm AG)
• Biomay AG
• Anergis SA
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Allergy Immunotherapy Market Regional Analysis

Region and country analysis section of Allergy Immunotherapy Industry Analysis has been segmented into 5 major region such as North America, Europe, Asia Pacific, Middle East & Africa ,and Latin America (along with respective major contributing countries) and provides the revenue share, current trends.

The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of Allergy Immunotherapy market.

The current report Scope analyzes Allergy Immunotherapy Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

Allergy Immunotherapy Market Analysis

Indication Segment Analysis of Allergy Immunotherapy Market

Allergic Rhinitis

Allergic rhinitis is an allergic reaction caused due to harmless allergen. The symptoms of allergic rhinitis include sneezing, runny, stuffy nose, coughing, watery eyes, eczema-type symptoms, and itchy eyes. The allergic rhinitis is caused due to ragweed allergen, a sublingual allergen tablet administered in the treatment with or without conjunctivitis. This allergy with or without conjunctivitis caused due to animal dander, dust mites, molds, and pollen. The Allergic Rhinitis Market Size will be USD 1,816.28 Million by 2028.

Allergic Asthma

The allergic asthma is an allergen causes reaction in lungs that leads to difficulty in breathing, wheezing. The allergic asthma reaction occurs due to birch trees, house dust mites, ragweed, pollen grains, animal dander allergens. The subcutaneous allergy shot treatment is also effective to treat allergic asthma. High-dose sublingual immunotherapy and specific allergen immunotherapy is effective treatment for asthmatic patients.

Food Allergy

Food allergy is caused due to consumption of allergen causing allergic reaction in patient. The oral immunotherapy is effective in treating food allergy, in which increasing amount of food allergen is consumed under supervision of doctors, this increases in the number of antibodies developed in the body to fight against food allergen and it reduces the severity of reaction. The severe food allergic reaction leads in potential anaphylaxis in patients. The most common food causing allergic reaction is peanuts, egg, cow milk, tree nuts, soy, sesame, wheat, fish, seafood such as crustaceans.

Atopic Dermatitis

Atopic dermatitis is known as eczema, a skin infection common in children leads to red and itchy skin. Atopic dermatitis patients are allergic to house dust mites and their exposure to eczema worsens the situation. Specific allergen immunotherapy has injection or drops under tongue containing the allergen reduces the severity of allergy.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Allergy Immunotherapy Industry. Request a Free Sample PDF!

Distribution Channel Segment Analysis of Allergy Immunotherapy Market

Hospital Pharmacy

Hospitals has immunologists that treats allergic patients an provide them effective treatment. The main focus of the hospital is to provide personalized care and service to diagnose and treat allergies. The scientifically diagnosed test and effective internationally recognized allergy treatment is used in the hospitals. Allergen vaccination, that is proved effective given for the allergic rhinitis, allergic conjunctivitis, allergic asthma, venom hypersensitivity treatment, atopic dermatitis. The doctor’s consults and gives effective treatment to patients in hospitals through sublingual, subcutaneous, tablet or orally administered medicine for allergy. The Hospital Pharmacy Revenue (USD Million) in Allergy Immunotherapy is estimated to reach USD 2,321.54 Million by 2028.

Retail Pharmacy

Healthcare institution in partnership with retail pharmacy stores are providing allergen specific immunotherapy medicines given orally, sublingual and subcutaneous route of administration. The allergic tablets, allergic shots are given to treat allergic rhinitis, atopic dermatitis, food allergy indications. The retail pharmacy provides allergic medicines to patients required for immunotherapy.

Online Pharmacy

Various immunotherapies drugs, such as sublingual, allergen tablets placed under tongue, oral immunotherapy allergic shots and tablets available at e-commerce platform.  The online sales of allergen specific immunotherapy are in higher demand in the market.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Allergy Immunotherapy Treatment Type Segment Analysis

Sublingual Immunotherapy

Sublingual immunotherapy is a treatment to treat allergies in cancer patients creating antibodies against infection and reducing the intensity of allergic reactions. Sublingual immunotherapy is treated by placing a tablet under the tongue, the drug is administered bypassing the gastrointestinal tract. The tablet dosage form is the FDA-approved treatment and allergy drops are not approved by the organization. The Sublingual Immunotherapy Revenue (USD Million) in Allergy Immunotherapy is projected to reach USD 3,366.19 Million by 2028.

Subcutaneous Immunotherapy

Allergy shots or injection is inserted into the skin through the parenteral route. A small amount of allergen is injected into the skin of the arm. thigh. Subcutaneous therapy is indicated for allergic conditions such as allergic rhinoconjunctivitis, allergic otitis media, and bronchial asthma.

• Sublingual Immunotherapy
• Subcutaneous Immunotherapy

Allergy Immunotherapy Allergy Type Segment Analysis

Birch/Tree Allergy

Allergy shots or immunotherapy allergy is a treatment to stop or reduce the effect of allergy. It has tiny amount of substance that triggers the allergic reactions. There are various allergens that stimulate the immune system of the patient’s body. Pollen is the common cause of allergies, these pollens are fine powder produced by trees, flowers, grasses and weeds to fertilize other plants of same species. Birch pollen is common airborne allergens causes reaction in the patient's body. The trees during spring release tiny pollen grains that are scattered by wind. The people which have allergy to birch pollen grains and trees, the immune system identifies the harmless pollen as dangerous antigen and starts to produce chemicals to fight against pollen and this allergic reaction causes symptoms sneezing, stuffy nose, watery eyes. A single birch tree produces around 5 million pollen grains that travels many travelling distances. Allergic shots or allergen tablets are given to treat birch tree allergic reaction. The Birch/Tree Allergy Revenue (USD Million) in Allergy Immunotherapy is anticipated reach USD 832.57 Million by 2028.

Ragweed Allergy

Ragweed plants are the main root cause of allergies among weed pollens, they are active between late spring and fall months. Ragweed spread its pollen in the week of July and continues till mid-month of October. Sublingual allergen tablets given to treat ragweed allergy immunotherapy treatment.

Grass Allergy

Grass leads to an allergic reaction, that leads to reaction in the patient. The immunotherapy such as allergic shots, tablets are effective in relieving symptoms of grass pollen allergies.

House Dust Mite Allergy

Dust mite allergy is small allergen that is in the house that can trigger allergic reaction and it causes serious side effects to asthma patients. Dust mites have 13 species, tiny cannot be seen by naked eye, they mainly feed on the tiny flakes of human skin, these mites adapt to the environment of home furniture, carpets. They cause allergic symptoms include sneezing, runny nose, itchy, red or watery eyes, itchy nose, mouth, postnasal drip, cough. The asthmatic patient face difficulty in breathing, chest tightness, pain, whistling or wheezing sound during breathing. Allergy shots are given through subcutaneous and sublingual route treatment, which is an effective option.

Insect Venom Allergy

Insect venom allergy is caused due to sting of insects. The allergy shots are given to reduce the sensitivity to allergens that can cause a reaction. Allergy shots reduce the severity of allergic reaction. The treatment includes use of small amount of venom of insect and the therapy is known as venom immunotherapy. The allergy shots injected under the skin.

Animal Dander

Animal dander is flex of skin shed of pet animal such as dog, cats. This allergic reaction occurs due to pet shed, dead flakes of skin. The symptoms of allergic reaction signs of asthma, breathing difficulty, wheezing. Animal fur, saliva is cause of pet allergy. Allergic shots or allergen specific immunotherapy treatment is given to treat the allergic reaction

• Birch/Tree Allergy
• Ragweed Allergy
• Grass Allergy
• House Dust Mite Allergy
• Insect Venom Allergy
• Animal Dander
• Others

The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of this market.

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion